marketcaparena
Search

    IART

    INTEGRA LIFESCIENCES HOLDINGS CORP

    Company overview

    Market capitalization
    $1.27B
    Employees
    4,427
    Latest publication
    2026-09-29
    About INTEGRA LIFESCIENCES HOLDINGS CORP

    Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USD
    Total Revenue418,761,000USD391,918,000USD434,925,000USD402,062,000USD442,646,000USD418,175,000USD368,872,000USD397,039,000USD
    Cost Of Revenue199,017,000USD167,681,000USD219,563,000USD175,954,000USD193,574,000USD192,258,000USD162,038,000USD170,546,000USD
    Gross Profit219,744,000USD224,237,000USD215,362,000USD226,108,000USD249,072,000USD225,917,000USD206,834,000USD226,493,000USD
    Selling General Administrative172,436,000USD178,235,000USD169,267,000USD169,046,000USD178,520,000USD195,472,000USD165,798,000USD163,128,000USD
    Other Operating Expenses3,770,000USD———————
    Total Operating Expenses200,459,000USD184,153,000USD-340,836,000USD185,817,000USD213,445,000USD228,946,000USD202,870,000USD190,446,000USD
    Operating Income19,285,000USD40,084,000USD556,198,000USD40,291,000USD35,627,000USD-3,029,000USD3,964,000USD36,047,000USD
    Total Other Income Expense Net-14,541,000USD-42,493,000USD-551,888,000USD-47,115,000USD-13,086,000USD-12,156,000USD-9,194,000USD-7,189,000USD
    Interest Income4,267,000USD4,106,000USD4,362,000USD4,982,000USD4,893,000USD5,058,000USD5,040,000USD4,549,000USD
    Interest Expense22,994,000USD26,845,000USD23,673,000USD22,725,000USD18,984,000USD18,651,000USD13,624,000USD13,751,000USD
    Income Before Tax4,744,000USD-2,409,000USD4,310,000USD-6,824,000USD22,541,000USD-15,185,000USD-5,230,000USD28,858,000USD
    Income Tax Expense262,000USD2,208,000USD6,014,000USD-1,420,000USD3,106,000USD-2,783,000USD-1,949,000USD9,024,000USD
    Net Income4,482,000USD-4,617,000USD-1,704,000USD-5,404,000USD19,435,000USD-12,402,000USD-3,281,000USD19,834,000USD
    Research Development—23,501,000USD24,791,000USD22,456,000USD31,210,000USD29,767,000USD26,965,000USD24,284,000USD
    Unclassified Operating Expenses—-17,583,000USD-534,894,000USD-5,685,000USD3,715,000USD3,707,000USD10,107,000USD3,034,000USD
    Net Interest Income—-18,359,000USD-19,311,000USD-17,743,000USD-14,091,000USD-13,593,000USD-8,584,000USD-9,202,000USD
    Tax Provision—2,208,000USD6,014,000USD-1,420,000USD3,106,000USD-2,783,000USD-1,949,000USD9,024,000USD
    Net Income From Continuing Ops—-4,617,000USD-1,704,000USD-5,404,000USD19,435,000USD-12,402,000USD-3,281,000USD19,834,000USD
    Ebit—24,436,000USD27,983,000USD15,901,000USD41,622,000USD3,466,000USD8,394,000USD42,609,000USD
    Ebitda—62,866,000USD65,988,000USD54,063,000USD79,114,000USD40,243,000USD38,960,000USD73,594,000USD
    Depreciation And Amortization—38,430,000USD38,005,000USD38,162,000USD37,492,000USD36,777,000USD30,566,000USD30,985,000USD
    Reconciled Depreciation—38,430,000USD38,430,000USD38,522,000USD37,589,000USD36,777,000USD30,566,000USD30,985,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,635,245,000USD1,610,527,000USD1,541,573,000USD1,557,666,000USD1,542,448,000USD1,371,868,000USD1,517,557,000USD1,472,441,000USD
    Cost Of Revenue790,011,000USD728,466,000USD656,838,000USD587,355,000USD597,808,000USD520,834,000USD564,681,000USD571,496,000USD
    Gross Profit845,234,000USD882,061,000USD884,735,000USD970,311,000USD944,640,000USD851,034,000USD952,876,000USD900,945,000USD
    Research Development98,971,000USD115,377,000USD104,192,000USD101,193,000USD93,051,000USD77,381,000USD79,573,000USD78,041,000USD
    Selling General Administrative699,700,000USD716,983,000USD656,641,000USD616,316,000USD637,445,000USD594,526,000USD687,599,000USD690,746,000USD
    Unclassified Operating Expenses-21,755,000USD21,290,000USD12,376,000USD13,882,000USD16,914,000USD27,757,000USD91,944,000USD21,160,000USD
    Total Operating Expenses776,916,000USD853,650,000USD773,209,000USD731,391,000USD747,410,000USD699,664,000USD859,116,000USD789,947,000USD
    Operating Income68,318,000USD28,411,000USD111,526,000USD238,920,000USD197,230,000USD151,370,000USD93,760,000USD110,998,000USD
    Interest Income18,474,000USD20,040,000USD17,202,000USD11,917,000USD6,737,000USD9,297,000USD10,779,000USD2,800,000USD
    Interest Expense86,255,000USD70,632,000USD51,377,000USD49,594,000USD50,395,000USD71,581,000USD53,957,000USD64,683,000USD
    Net Interest Income-67,781,000USD-50,592,000USD-34,175,000USD-37,677,000USD-43,658,000USD-62,284,000USD-43,178,000USD-61,883,000USD
    Income Before Tax-563,502,000USD-18,237,000USD81,069,000USD213,894,000USD214,677,000USD93,520,000USD60,104,000USD57,403,000USD
    Income Tax Expense-47,028,000USD-11,293,000USD13,328,000USD33,344,000USD45,602,000USD-40,372,000USD9,903,000USD-3,398,000USD
    Tax Provision-47,028,000USD-11,293,000USD13,328,000USD33,344,000USD45,602,000USD-40,372,000USD9,903,000USD-3,398,000USD
    Net Income-516,474,000USD-6,944,000USD67,741,000USD180,550,000USD169,075,000USD133,892,000USD50,201,000USD60,801,000USD
    Net Income From Continuing Ops-516,474,000USD-6,944,000USD67,741,000USD180,550,000USD169,075,000USD133,892,000USD50,201,000USD60,801,000USD
    Ebit-477,247,000USD52,788,000USD132,446,000USD263,488,000USD242,661,000USD148,947,000USD114,061,000USD125,338,000USD
    Ebitda-326,200,000USD193,288,000USD255,958,000USD384,603,000USD366,331,000USD267,933,000USD223,523,000USD241,038,000USD
    Depreciation And Amortization151,047,000USD140,500,000USD123,512,000USD121,115,000USD123,670,000USD118,986,000USD109,462,000USD115,700,000USD
    Reconciled Depreciation151,832,000USD140,893,000USD123,512,000USD118,299,000USD16,914,000USD116,031,000USD109,462,000USD110,730,000USD
    Total Other Income Expense Net-631,820,000USD-46,648,000USD-30,457,000USD-25,026,000USD17,447,000USD-57,850,000USD-33,656,000USD-53,595,000USD
    Non Operating Income Net Other———24,568,000USD67,842,000USD13,731,000USD20,301,000USD11,088,000USD
    Net Income Applicable To Common Shares———180,550,000USD169,075,000USD133,892,000USD50,201,000USD60,801,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets3,563,490,000USD3,577,726,000USD3,602,001,000USD3,646,452,000USD3,667,905,000USD971,159,000USD4,037,424,000USD4,065,803,000USD
    Cash And Equivalents214,415,000USD———————
    Cash And Short Term Investments274,084,000USD265,502,000USD263,741,000USD267,879,000USD253,608,000USD273,295,000USD273,567,000USD277,598,000USD
    Short Term Investments59,669,000USD28,693,000USD28,693,000USD35,693,000USD35,694,000USD34,191,000USD27,192,000USD62,441,000USD
    Total Current Assets1,191,482,000USD1,172,017,000USD1,159,544,000USD1,143,582,000USD1,142,828,000USD971,159,000USD1,081,681,000USD1,099,522,000USD
    Other Current Assets53,861,000USD147,067,000USD124,219,000USD124,437,000USD139,586,000USD32,214,000USD106,654,000USD136,696,000USD
    Other Non Current Assets31,591,000USD———————
    Total Liabilities2,520,113,000USD———————
    Total Current Liabilities330,881,000USD346,846,000USD455,981,000USD364,054,000USD929,806,000USD918,452,000USD922,126,000USD912,563,000USD
    Other Current Liabilities107,618,000USD———————
    Other Non Current Liabilities194,397,000USD———————
    Total Stockholder Equity1,043,377,000USD1,042,406,000USD1,043,463,000USD1,037,574,000USD1,038,661,000USD1,524,139,000USD1,545,280,000USD1,521,587,000USD
    Total Equity Including Noncontrolling Interest1,043,377,000USD———————
    Deferred Revenue11,699,000USD———————
    Net Receivables267,188,000USD264,413,000USD278,849,000USD262,160,000USD284,507,000USD252,446,000USD272,370,000USD248,298,000USD
    Inventory492,005,000USD495,035,000USD492,735,000USD489,106,000USD465,127,000USD445,418,000USD429,090,000USD436,930,000USD
    Property Plant Equipment Net583,287,000USD584,079,000USD584,903,000USD575,554,000USD571,388,000USD561,376,000USD549,765,000USD537,248,000USD
    Goodwill611,145,000USD———————
    Intangible Assets1,075,542,000USD1,105,345,000USD1,134,663,000USD1,160,145,000USD1,188,080,000USD1,187,535,000USD1,207,588,000USD1,209,548,000USD
    Accounts Payable82,637,000USD87,948,000USD95,726,000USD92,305,000USD92,835,000USD91,296,000USD82,502,000USD77,666,000USD
    Short Term Debt13,920,000USD52,682,000USD140,569,000USD52,576,000USD627,554,000USD626,820,000USD621,616,000USD616,544,000USD
    Common Stock921,000USD922,000USD923,000USD923,000USD923,000USD921,000USD916,000USD916,000USD
    Retained Earnings423,306,000USD418,824,000USD423,441,000USD425,145,000USD430,549,000USD914,622,000USD939,915,000USD920,481,000USD
    Accumulated Other Comprehensive Income-40,197,000USD-30,940,000USD-30,077,000USD-31,975,000USD-30,907,000USD-24,106,000USD-27,571,000USD-24,854,000USD
    Total Liab—2,535,320,000USD2,558,538,000USD2,608,878,000USD2,629,244,000USD2,528,612,000USD2,492,144,000USD2,544,216,000USD
    Other Current Liab—194,593,000USD208,223,000USD207,847,000USD198,314,000USD189,797,000USD207,525,000USD208,363,000USD
    Capital Stock—922,000USD923,000USD923,000USD923,000USD921,000USD916,000USD916,000USD
    Good Will—613,247,000USD615,157,000USD615,199,000USD616,427,000USD1,105,386,000USD1,096,952,000USD1,116,535,000USD
    Cash—236,809,000USD235,048,000USD232,186,000USD217,914,000USD239,104,000USD246,375,000USD215,157,000USD
    Current Deferred Revenue—11,623,000USD11,463,000USD11,326,000USD11,103,000USD10,539,000USD10,483,000USD9,990,000USD
    Net Debt—1,802,644,000USD1,798,136,000USD1,773,674,000USD1,795,855,000USD1,794,004,000USD1,738,188,000USD1,774,287,000USD
    Short Long Term Debt—38,750,000USD126,550,000USD38,750,000USD613,378,000USD612,649,000USD607,076,000USD601,505,000USD
    Short Long Term Debt Total—2,039,453,000USD2,033,184,000USD2,005,860,000USD2,013,769,000USD2,018,937,000USD1,984,563,000USD1,989,444,000USD
    Long Term Debt—1,826,655,000USD1,729,556,000USD1,792,351,000USD1,226,942,000USD1,230,641,000USD1,196,017,000USD1,205,092,000USD
    Property Plant Equipment Gross—584,079,000USD1,028,854,000USD575,554,000USD571,388,000USD561,376,000USD946,688,000USD537,248,000USD
    Common Stock Shares Outstanding—76,951,000shares76,753,000shares76,753,000shares76,463,000shares76,463,000shares77,010,000shares76,448,000shares
    Non Current Assets Total—2,405,709,000USD2,442,457,000USD2,502,870,000USD2,525,077,000USD2,945,504,000USD2,955,743,000USD2,966,281,000USD
    Non Current Liabilities Total—2,188,474,000USD2,102,557,000USD2,244,824,000USD1,699,438,000USD1,610,160,000USD1,570,018,000USD1,631,653,000USD
    Non Current Liabilities Other—195,560,000USD204,278,000USD233,255,000USD253,159,000USD160,462,000USD146,238,000USD189,808,000USD
    Non Currrent Assets Other—22,809,000USD25,102,000USD26,706,000USD27,737,000USD53,199,000USD28,213,000USD27,553,000USD
    Net Working Capital—825,171,000USD703,563,000USD779,528,000USD213,022,000USD188,795,000USD159,555,000USD186,959,000USD
    Unclassified Non Current Assets—80,229,000USD82,632,000USD125,266,000USD121,445,000USD38,008,000USD73,225,000USD75,397,000USD
    Unclassified Current Liabilities—-38,750,000USD-126,550,000USD-38,750,000USD-613,378,000USD-612,649,000USD-607,076,000USD-601,505,000USD
    Unclassified Non Current Liabilities—166,259,000USD168,723,000USD219,218,000USD219,337,000USD219,057,000USD227,763,000USD236,753,000USD
    Unclassified Equity—652,678,000USD648,253,000USD642,558,000USD637,173,000USD631,781,000USD631,104,000USD624,128,000USD
    Unclassified Current Assets—————-32,214,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets3,602,001,000USD4,037,424,000USD3,781,988,000USD3,889,758,000USD3,782,383,000USD3,615,136,000USD3,303,240,000USD3,107,887,000USD
    Intangible Assets1,134,663,000USD1,207,588,000USD1,067,833,000USD1,126,609,000USD1,145,573,000USD989,436,000USD1,031,591,000USD1,079,496,000USD
    Other Current Assets124,219,000USD106,654,000USD100,005,000USD116,789,000USD79,639,000USD231,387,000USD67,907,000USD90,160,000USD
    Total Liab2,558,538,000USD2,492,144,000USD2,194,104,000USD2,085,355,000USD2,097,579,000USD2,100,269,000USD1,886,504,000USD1,732,091,000USD
    Total Stockholder Equity1,043,463,000USD1,545,280,000USD1,587,884,000USD1,804,403,000USD1,684,804,000USD1,514,867,000USD1,416,736,000USD1,375,796,000USD
    Other Current Liab204,572,000USD207,525,000USD176,299,000USD144,180,000USD198,339,000USD182,062,000USD143,941,000USD160,238,000USD
    Common Stock923,000USD916,000USD909,000USD905,000USD896,000USD893,000USD887,000USD880,000USD
    Capital Stock923,000USD916,000USD909,000USD905,000USD896,000USD893,000USD887,000USD880,000USD
    Retained Earnings423,441,000USD939,915,000USD946,859,000USD879,118,000USD698,568,000USD532,265,000USD398,574,000USD348,373,000USD
    Good Will615,157,000USD1,096,952,000USD1,055,462,000USD1,038,881,000USD1,013,458,000USD932,367,000USD954,280,000USD926,475,000USD
    Cash235,048,000USD246,375,000USD276,402,000USD456,661,000USD513,448,000USD470,166,000USD198,911,000USD138,838,000USD
    Cash And Short Term Investments263,741,000USD273,567,000USD309,096,000USD456,661,000USD513,448,000USD470,166,000USD198,911,000USD138,838,000USD
    Total Current Assets1,159,544,000USD1,081,681,000USD1,058,036,000USD1,161,498,000USD1,153,716,000USD1,237,202,000USD858,168,000USD775,082,000USD
    Total Current Liabilities455,981,000USD922,126,000USD306,980,000USD320,906,000USD340,021,000USD401,013,000USD331,309,000USD262,552,000USD
    Current Deferred Revenue11,463,000USD10,483,000USD8,540,000USD7,253,000USD5,295,000USD5,275,000USD4,772,000USD3,764,000USD
    Net Debt1,798,136,000USD1,738,188,000USD1,405,280,000USD1,173,322,000USD1,152,614,000USD1,185,241,000USD1,258,907,000USD1,215,375,000USD
    Short Term Debt140,569,000USD621,616,000USD29,815,000USD67,373,000USD74,550,000USD159,068,000USD69,506,000USD22,500,000USD
    Short Long Term Debt126,550,000USD607,076,000USD14,531,000USD38,125,000USD45,000,000USD146,250,000USD45,000,000USD22,500,000USD
    Short Long Term Debt Total2,033,184,000USD1,984,563,000USD1,681,682,000USD1,629,983,000USD1,666,062,000USD1,655,407,000USD1,457,818,000USD1,354,213,000USD
    Long Term Debt1,729,556,000USD1,196,017,000USD1,485,018,000USD1,300,490,000USD1,388,683,000USD1,408,221,000USD1,198,561,000USD1,210,513,000USD
    Short Term Investments28,693,000USD27,192,000USD32,694,000USD16,682,000USD——12,000USD4,654,000USD
    Net Receivables278,849,000USD272,370,000USD259,327,000USD263,465,000USD243,243,000USD225,532,000USD275,296,000USD265,737,000USD
    Inventory492,735,000USD429,090,000USD389,608,000USD324,583,000USD317,386,000USD310,117,000USD316,054,000USD280,347,000USD
    Accounts Payable95,726,000USD82,502,000USD92,326,000USD102,100,000USD61,837,000USD54,608,000USD113,090,000USD76,050,000USD
    Property Plant Equipment Net584,903,000USD549,765,000USD496,383,000USD459,586,000USD396,246,000USD371,164,000USD431,934,000USD300,112,000USD
    Property Plant Equipment Gross1,028,854,000USD946,688,000USD863,830,000USD789,315,000USD711,120,000USD371,164,000USD431,934,000USD300,112,000USD
    Accumulated Other Comprehensive Income-30,077,000USD-27,571,000USD-15,106,000USD10,265,000USD-45,155,000USD-74,059,000USD-76,402,000USD-45,443,000USD
    Common Stock Shares Outstanding76,753,000shares77,010,000shares80,337,000shares83,516,000shares85,485,000shares85,228,000shares86,494,000shares84,445,833shares
    Non Current Assets Total2,442,457,000USD2,955,743,000USD2,723,952,000USD2,728,260,000USD2,628,667,000USD2,377,934,000USD2,445,072,000USD2,332,805,000USD
    Non Current Liabilities Total2,102,557,000USD1,570,018,000USD1,887,124,000USD1,764,449,000USD1,757,558,000USD1,699,256,000USD1,555,195,000USD1,469,539,000USD
    Non Current Liabilities Other204,278,000USD146,238,000USD199,940,000USD400,621,000USD323,087,000USD274,845,000USD320,081,000USD201,248,000USD
    Non Currrent Assets Other25,102,000USD28,213,000USD27,484,000USD-510,151,000USD9,963,000USD-463,557,000USD11,179,000USD14,567,000USD
    Net Working Capital703,563,000USD159,555,000USD751,056,000USD840,592,000USD813,695,000USD836,189,000USD526,859,000USD512,530,000USD
    Unclassified Non Current Assets82,632,000USD73,225,000USD76,790,000USD40,030,000USD-3,718,956,000USD-83,635,000USD——
    Unclassified Current Liabilities-122,899,000USD-607,076,000USD-14,531,000USD-38,125,000USD-45,000,000USD-146,250,000USD-45,000,000USD-22,500,000USD
    Unclassified Non Current Liabilities168,723,000USD227,763,000USD202,166,000USD-201,839,000USD-135,903,000USD-131,181,000USD-116,108,000USD-128,441,000USD
    Unclassified Equity648,253,000USD631,104,000USD654,313,000USD1,276,072,000USD1,264,047,000USD1,290,016,000USD1,212,733,000USD1,191,721,000USD
    Deferred Long Term Liab———63,338,000USD45,788,000USD16,190,000USD36,553,000USD57,778,000USD
    Other Liab———201,839,000USD135,903,000USD131,181,000USD116,108,000USD128,441,000USD
    Other Assets———63,154,000USD3,782,383,000USD168,602,000USD27,267,000USD21,372,000USD
    Treasury Stock———-362,862,000USD-234,448,000USD-235,141,000USD-119,943,000USD-120,615,000USD
    Net Tangible Assets———-361,087,000USD-474,227,000USD-406,936,000USD-569,135,000USD-630,175,000USD
    Unclassified Current Assets———-16,682,000USD————
    Long Term Investments———————5,350,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-4,617,000USD-1,704,000USD-5,404,000USD-484,073,000USD-25,293,000USD19,435,000USD-10,696,000USD-12,402,000USD
    Depreciation38,430,000USD38,430,000USD38,522,000USD37,692,000USD37,188,000USD37,589,000USD35,961,000USD36,777,000USD
    Stock Based Compensation5,165,000USD5,838,000USD5,580,000USD5,295,000USD1,870,000USD7,152,000USD4,382,000USD7,244,000USD
    Other Non Cash Items122,000USD-4,452,000USD-13,437,000USD512,868,000USD1,464,000USD5,539,000USD-20,532,000USD9,688,000USD
    Change To Account Receivables13,645,000USD-16,452,000USD22,507,000USD-27,991,000USD21,451,000USD-31,463,000USD28,750,000USD-6,716,000USD
    Change To Inventory-4,329,000USD-3,341,000USD-23,345,000USD-6,378,000USD-13,696,000USD-570,000USD-10,301,000USD1,743,000USD
    Change In Working Capital-30,623,000USD-15,348,000USD24,298,000USD-18,032,000USD-24,654,000USD-11,987,000USD22,413,000USD938,000USD
    Total Cash From Operating Activities9,803,000USD11,816,000USD40,906,000USD8,919,000USD-11,257,000USD50,740,000USD22,485,000USD40,401,000USD
    Capital Expenditures-14,848,000USD-31,416,000USD-15,156,000USD-20,146,000USD-28,920,000USD-39,553,000USD-29,646,000USD-29,707,000USD
    Free Cash Flow-5,045,000USD-19,600,000USD25,750,000USD-11,227,000USD-40,177,000USD11,187,000USD-7,161,000USD10,694,000USD
    Investments0USD-3,491,000USD-15,588,000USD-21,648,000USD-35,920,000USD-4,249,000USD-10,396,000USD-322,198,000USD
    Total Cashflows From Investing Activities-14,848,000USD-34,907,000USD-15,588,000USD-21,648,000USD-35,920,000USD-4,249,000USD-10,396,000USD-322,198,000USD
    Net Borrowings8,912,000USD24,613,000USD-9,971,000USD-2,987,000USD39,156,000USD-4,543,000USD-19,744,000USD—
    Total Cash From Financing Activities8,297,000USD24,342,000USD-10,245,000USD-21,139,000USD35,377,000USD-7,150,000USD-19,915,000USD-93,748,000USD
    Change In Cash1,761,000USD2,862,000USD14,272,000USD-21,190,000USD-7,271,000USD31,218,000USD-79,000USD-376,670,000USD
    Begin Period Cash Flow235,048,000USD232,186,000USD217,914,000USD239,104,000USD246,375,000USD215,157,000USD215,236,000USD591,906,000USD
    End Period Cash Flow236,809,000USD235,048,000USD232,186,000USD217,914,000USD239,104,000USD246,375,000USD215,157,000USD215,236,000USD
    Other Cashflows From Financing Activities-1,375,000USD-271,000USD-75,000USD-14,076,000USD-4,736,000USD-136,000USD-171,000USD-12,004,000USD
    Unclassified Operating Cash Flow1,326,000USD-10,948,000USD-8,653,000USD-44,831,000USD-1,832,000USD-6,988,000USD-9,043,000USD-1,844,000USD
    Sale Purchase Of Stock—-221,000USD-199,000USD-221,000USD—-2,471,000USD-171,000USD-50,000,000USD
    Other Cashflows From Investing Activities—-14,202,000USD-37,236,000USD-57,568,000USD-35,920,000USD-9,953,000USD—-10,497,000USD
    Unclassified Investing Cash Flow—14,202,000USD52,392,000USD77,714,000USD64,840,000USD49,506,000USD29,646,000USD40,204,000USD
    Unclassified Financing Cash Flow———-3,855,000USD———-31,744,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-516,474,000USD-6,944,000USD67,741,000USD180,550,000USD169,075,000USD133,892,000USD50,201,000USD60,801,000USD
    Depreciation151,832,000USD140,893,000USD123,512,000USD118,299,000USD119,836,000USD116,031,000USD109,462,000USD110,730,000USD
    Stock Based Compensation18,583,000USD24,377,000USD20,143,000USD27,725,000USD36,210,000USD19,590,000USD21,255,000USD20,779,000USD
    Other Non Cash Items496,443,000USD22,794,000USD22,018,000USD-18,100,000USD-28,102,000USD39,771,000USD84,070,000USD13,810,000USD
    Change To Account Receivables-485,000USD7,398,000USD4,593,000USD-33,905,000USD7,265,000USD52,105,000USD-9,428,000USD-17,021,000USD
    Change To Inventory-46,760,000USD-28,149,000USD-59,773,000USD-29,124,000USD5,374,000USD-48,348,000USD-43,308,000USD8,300,000USD
    Change In Working Capital-33,736,000USD-31,007,000USD-81,574,000USD-39,420,000USD18,163,000USD-41,314,000USD-14,509,000USD1,747,000USD
    Total Cash From Operating Activities50,384,000USD129,382,000USD139,955,000USD264,469,000USD312,427,000USD203,832,000USD231,433,000USD199,683,000USD
    Capital Expenditures-95,638,000USD-104,418,000USD-66,865,000USD-47,085,000USD-48,080,000USD-63,890,000USD-134,532,000USD-77,741,000USD
    Free Cash Flow-45,254,000USD24,964,000USD73,090,000USD217,384,000USD264,347,000USD139,942,000USD96,901,000USD121,942,000USD
    Investments-12,425,000USD-390,808,000USD-94,178,000USD4,909,000USD76,000USD-7,840,000USD2,336,000USD910,000USD
    Total Cashflows From Investing Activities-108,063,000USD-390,808,000USD-94,178,000USD-58,580,000USD-161,443,000USD-68,073,000USD-162,668,000USD-49,705,000USD
    Net Borrowings50,811,000USD299,369,000USD54,500,000USD-107,800,000USD-100,249,000USD281,153,000USD-9,200,000USD-493,837,000USD
    Total Cash From Financing Activities28,335,000USD237,863,000USD-229,925,000USD-251,953,000USD-98,226,000USD121,625,000USD-8,766,000USD-180,872,000USD
    Sale Purchase Of Stock-221,000USD-52,471,000USD-275,000,000USD-125,000,000USD-4,801,000USD-100,000,000USD-6,514,000USD-7,821,000USD
    Change In Cash-11,327,000USD-30,027,000USD-180,259,000USD-56,787,000USD43,282,000USD271,255,000USD60,073,000USD-36,097,000USD
    Begin Period Cash Flow246,375,000USD276,402,000USD456,661,000USD513,448,000USD470,166,000USD198,911,000USD138,838,000USD174,935,000USD
    End Period Cash Flow235,048,000USD246,375,000USD276,402,000USD456,661,000USD513,448,000USD470,166,000USD198,911,000USD138,838,000USD
    Other Cashflows From Investing Activities-14,202,000USD-14,082,000USD-1USD16,054,000USD-55,000USD-21,343,000USD-64,206,000USD1,332,000USD
    Other Cashflows From Financing Activities-19,148,000USD-9,035,000USD-9,425,000USD-19,153,000USD-5,050,000USD766,873,000USD434,000USD-41,662,000USD
    Unclassified Operating Cash Flow-66,264,000USD-20,731,000USD-11,885,000USD-4,585,000USD—-64,138,000USD-19,046,000USD-8,184,000USD
    Unclassified Investing Cash Flow14,202,000USD118,500,000USD66,865,001USD-32,458,000USD-113,384,000USD25,000,000USD33,734,000USD25,794,000USD
    Unclassified Financing Cash Flow-3,107,000USD—93,242,000USD5,465,000USD13,897,000USD-781,838,000USD6,948,000USD362,448,000USD
    Dividends Paid——-93,242,000USD-5,465,000USD-2,023,000USD-44,563,000USD-434,000USD—
    Change To Liabilities———12,905,000USD18,764,000USD-60,401,000USD12,607,000USD3,979,000USD
    Cash And Cash Equivalents Changes———-46,064,000USD52,758,000USD257,384,000USD59,999,000USD-36,097,000USD
    Issuance Of Capital Stock—————0USD0USD349,590,000USD
    Exchange Rate Changes———————-5,203,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyAsia Pacific48,697,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyEurope42,572,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyRest of World20,393,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States307,099,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentSpecialty Surgery309,269,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentTissue Reconstruction109,492,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific45,212,000USD0000917520-26-000041
    Q1 2026Quarterly · 2026-03-31GeographyEurope39,962,000USD0000917520-26-000041
    Q1 2026Quarterly · 2026-03-31GeographyRest of World17,364,000USD0000917520-26-000041
    Q1 2026Quarterly · 2026-03-31GeographyUnited States289,380,000USD0000917520-26-000041
    Q1 2026Quarterly · 2026-03-31SegmentSpecialty Surgery283,135,000USD0000917520-26-000041
    Q1 2026Quarterly · 2026-03-31SegmentTissue Reconstruction108,783,000USD0000917520-26-000041
    Q4 2025Quarterly · 2025-12-31GeographyAsia Pacific53,734,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyEurope41,853,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyRest of World18,964,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States320,374,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentCodman Specialty Surgical323,306,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentTissue Technologies111,619,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific189,251,000USD0000917520-26-000011
    FY 2025Yearly · 2025-12-31GeographyEurope162,666,000USD0000917520-26-000011
    FY 2025Yearly · 2025-12-31GeographyRest of World78,583,000USD0000917520-26-000011
    FY 2025Yearly · 2025-12-31GeographyUnited States1,204,745,000USD0000917520-26-000011
    FY 2025Yearly · 2025-12-31SegmentCodman Specialty Surgical1,200,511,000USD0000917520-26-000011
    FY 2025Yearly · 2025-12-31SegmentTissue Technologies434,734,000USD0000917520-26-000011
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific42,680,000USD0000917520-25-000096
    Q3 2025Quarterly · 2025-09-30GeographyEurope42,893,000USD0000917520-25-000096
    Q3 2025Quarterly · 2025-09-30GeographyRest of World20,643,000USD0000917520-25-000096
    Q3 2025Quarterly · 2025-09-30GeographyUnited States295,846,000USD0000917520-25-000096
    Q3 2025Quarterly · 2025-09-30SegmentCodman Specialty Surgical292,583,000USD0000917520-25-000096
    Q3 2025Quarterly · 2025-09-30SegmentTissue Technologies109,479,000USD0000917520-25-000096
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific47,732,000USD0000917520-25-000074
    Q2 2025Quarterly · 2025-06-30GeographyEurope42,594,000USD0000917520-25-000074
    Q2 2025Quarterly · 2025-06-30GeographyRest of World18,971,000USD0000917520-25-000074
    Q2 2025Quarterly · 2025-06-30GeographyUnited States306,308,000USD0000917520-25-000074
    Q2 2025Quarterly · 2025-06-30SegmentCodman Specialty Surgical303,958,000USD0000917520-25-000074
    Q2 2025Quarterly · 2025-06-30SegmentTissue Technologies111,647,000USD0000917520-25-000074
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific45,105,000USD0000917520-26-000041
    Q1 2025Quarterly · 2025-03-31GeographyEurope35,326,000USD0000917520-26-000041
    Q1 2025Quarterly · 2025-03-31GeographyRest of World20,005,000USD0000917520-26-000041
    Q1 2025Quarterly · 2025-03-31GeographyUnited States282,217,000USD0000917520-26-000041
    Q1 2025Quarterly · 2025-03-31SegmentSpecialty Surgery280,664,000USD0000917520-26-000041
    Q1 2025Quarterly · 2025-03-31SegmentTissue Reconstruction101,989,000USD0000917520-26-000041
    Q4 2024Quarterly · 2024-12-31GeographyAsia Pacific44,066,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyEurope41,843,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyRest of World20,708,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States336,029,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentCodman Specialty Surgical314,659,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentTissue Technologies127,987,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific176,614,000USD0000917520-26-000011
    FY 2024Yearly · 2024-12-31GeographyEurope158,496,000USD0000917520-26-000011
    FY 2024Yearly · 2024-12-31GeographyRest of World82,742,000USD0000917520-26-000011
    FY 2024Yearly · 2024-12-31GeographyUnited States1,192,675,000USD0000917520-26-000011
    FY 2024Yearly · 2024-12-31SegmentCodman Specialty Surgical1,143,636,000USD0000917520-26-000011
    FY 2024Yearly · 2024-12-31SegmentTissue Technologies466,891,000USD0000917520-26-000011
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific37,052,000USD0000917520-25-000096
    Q3 2024Quarterly · 2024-09-30GeographyEurope34,368,000USD0000917520-25-000096
    Q3 2024Quarterly · 2024-09-30GeographyRest of World19,222,000USD0000917520-25-000096
    Q3 2024Quarterly · 2024-09-30GeographyUnited States290,192,000USD0000917520-25-000096
    Q3 2024Quarterly · 2024-09-30SegmentCodman Specialty Surgical270,782,000USD0000917520-25-000096
    Q3 2024Quarterly · 2024-09-30SegmentTissue Technologies110,052,000USD0000917520-25-000096
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific193,096,000USD0000917520-26-000011
    FY 2023Yearly · 2023-12-31GeographyEurope165,221,000USD0000917520-26-000011
    FY 2023Yearly · 2023-12-31GeographyRest of World82,526,000USD0000917520-26-000011
    FY 2023Yearly · 2023-12-31GeographyUnited States1,100,730,000USD0000917520-26-000011
    FY 2023Yearly · 2023-12-31SegmentCodman Specialty Surgical1,058,993,000USD0000917520-26-000011
    FY 2023Yearly · 2023-12-31SegmentTissue Technologies482,580,000USD0000917520-26-000011
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific176,477,000USD0000917520-25-000017
    FY 2022Yearly · 2022-12-31GeographyEurope170,903,000USD0000917520-25-000017
    FY 2022Yearly · 2022-12-31GeographyRest of World83,476,000USD0000917520-25-000017
    FY 2022Yearly · 2022-12-31GeographyUnited States1,126,810,000USD0000917520-25-000017
    FY 2022Yearly · 2022-12-31SegmentCodman Specialty Surgical1,019,564,000USD0000917520-25-000017
    FY 2022Yearly · 2022-12-31SegmentTissue Technologies538,102,000USD0000917520-25-000017
    FY 2021Yearly · 2021-12-31GeographyAsia Pacific182,034,000USD0000917520-24-000022
    FY 2021Yearly · 2021-12-31GeographyEurope191,327,000USD0000917520-24-000022
    FY 2021Yearly · 2021-12-31GeographyRest of World79,561,000USD0000917520-24-000022
    FY 2021Yearly · 2021-12-31GeographyUnited States1,089,526,000USD0000917520-24-000022
    FY 2021Yearly · 2021-12-31SegmentCodman Specialty Surgical1,025,232,000USD0000917520-24-000022
    FY 2021Yearly · 2021-12-31SegmentTissue Technologies517,216,000USD0000917520-24-000022
    FY 2020Yearly · 2020-12-31GeographyAsia Pacific157,174,000USD0000917520-23-000015
    FY 2020Yearly · 2020-12-31GeographyEurope172,689,000USD0000917520-23-000015
    FY 2020Yearly · 2020-12-31GeographyRest of World70,030,000USD0000917520-23-000015
    FY 2020Yearly · 2020-12-31GeographyUnited States971,975,000USD0000917520-23-000015
    FY 2020Yearly · 2020-12-31SegmentCodman Specialty Surgical894,831,000USD0000917520-23-000015
    FY 2020Yearly · 2020-12-31SegmentTissue Technologies477,037,000USD0000917520-23-000015
    FY 2019Yearly · 2019-12-31GeographyAsia Pacific157,391,000USD0000917520-22-000010
    FY 2019Yearly · 2019-12-31GeographyEurope197,468,000USD0000917520-22-000010
    FY 2019Yearly · 2019-12-31GeographyRest of World85,319,000USD0000917520-22-000010
    FY 2019Yearly · 2019-12-31GeographyUnited States1,077,379,000USD0000917520-22-000010
    FY 2019Yearly · 2019-12-31SegmentCodman Specialty Surgical996,206,000USD0000917520-22-000010
    FY 2019Yearly · 2019-12-31SegmentTissue Technologies521,351,000USD0000917520-22-000010
    FY 2018Yearly · 2018-12-31GeographyAsia Pacific144,253,000USD0000917520-21-000018
    FY 2018Yearly · 2018-12-31GeographyEurope201,354,000USD0000917520-21-000018
    FY 2018Yearly · 2018-12-31GeographyRest of World80,947,000USD0000917520-21-000018
    FY 2018Yearly · 2018-12-31GeographyUnited States1,045,887,000USD0000917520-21-000018
    FY 2018Yearly · 2018-12-31SegmentCodman Specialty Surgical963,929,000USD0000917520-21-000018
    FY 2018Yearly · 2018-12-31SegmentOrthopedicsand Tissue Technologies508,512,000USD0000917520-21-000018
    Q3 2014Quarterly · 2014-09-30ProductInstruments45,980,000USD0000917520-14-000045
    Q3 2014Quarterly · 2014-09-30ProductNeurosurgery92,089,000USD0000917520-14-000045
    Q3 2014Quarterly · 2014-09-30ProductOrthopedics91,650,000USD0000917520-14-000045
    Q2 2014Quarterly · 2014-06-30ProductInstruments45,024,000USD0000917520-14-000028

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.